(Q46883280)

26 December 2017

title

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma (English)

1 reference

26 December 2017

3

Iva Sedláková

1 reference

26 December 2017

author name string

Markéta Tomsová

series ordinal

1

1 reference

26 December 2017

Bohuslav Melichar

series ordinal

2

1 reference

26 December 2017

Ivo Steiner

series ordinal

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

26 November 2007

1 reference

26 December 2017

published in

Gynecologic Oncology

1 reference

26 December 2017

volume

108

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

415-420

1 reference

26 December 2017

Identification of prognostic factors in advanced epithelial ovarian carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

"Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Histopathologic grading of ovarian carcinoma: a review and proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Steroid hormone receptors and long term survival in invasive ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

p21 and p53 in ovarian carcinoma: their combined staining is more valuable than either alone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

The immunotherapy of patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.016

10.1016/J.YGYNO.2007.10.016

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017